ACTIVE_NOT_RECRUITING

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Talk to us

Conditions

Idiopathic Pulmonary FibrosisBMS-986278LPA1 antagonistIPFPulmonary fibrosis

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.

Official Title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Quick Facts

Study Start:2023-09-14
Study Completion:2026-10-26
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06003426

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Bristol-Myers Squibb
STUDY_DIRECTOR
Bristol-Myers Squibb

Study Locations (Sites)

Local Institution - 0189
Birmingham, Alabama, 35294
United States
Local Institution - 0361
Phoenix, Arizona, 85013-4220
United States
Local Institution - 0396
La Jolla, California, 92037-1027
United States
Local Institution - 0193
Los Angeles, California, 90033-5313
United States
Local Institution - 0398
Los Angeles, California, 90095-3075
United States
Local Institution - 0389
Orange, California, 92868-3201
United States
Local Institution - 0405
Sacramento, California, 95817
United States
Local Institution - 0185
San Francisco, California, 94143-2202
United States
Local Institution - 0186
Stanford, California, 94305
United States
Local Institution - 0363
Aurora, Colorado, 80045
United States
Local Institution - 0194
Denver, Colorado, 80206
United States
Local Institution - 0175
New Haven, Connecticut, 06510
United States
Local Institution - 0151
Newark, Delaware, 19713-1337
United States
Local Institution - 0367
Washington D.C., District of Columbia, 20007-2113
United States
Local Institution - 0101
Brandon, Florida, 33511-5706
United States
Local Institution - 0436
Clearwater, Florida, 33765
United States
Local Institution - 0425
DeBary, Florida, 32713-1817
United States
Local Institution - 0079
Gainesville, Florida, 32610
United States
Local Institution - 0352
Hialeah, Florida, 33016
United States
Local Institution - 0370
Kissimmee, Florida, 34746-4654
United States
Local Institution - 0502
Leesburg, Florida, 34748-5077
United States
Local Institution - 0153
Loxahatchee Groves, Florida, 33411
United States
Local Institution - 0187
Ocala, Florida, 34471
United States
Local Institution - 0418
Pensacola, Florida, 32503-2670
United States
Local Institution - 0206
St. Petersburg, Florida, 33704
United States
Local Institution - 0364
Tampa, Florida, 33606
United States
Local Institution - 0372
Dublin, Georgia, 31021-2561
United States
Local Institution - 0178
Chicago, Illinois, 60611
United States
Local Institution - 0183
Chicago, Illinois, 60612-3841
United States
Local Institution - 0058
Chicago, Illinois, 60637
United States
Local Institution - 0085
Maywood, Illinois, 60153-3328
United States
Local Institution - 0325
Peoria, Illinois, 61637-0001
United States
Local Institution - 0180
Iowa City, Iowa, 522242-1009
United States
Local Institution - 0204
Kansas City, Kansas, 66160
United States
Local Institution - 0393
Louisville, Kentucky, 40202-1332
United States
Local Institution - 0354
Baltimore, Maryland, 21201-1544
United States
Local Institution - 0380
Boston, Massachusetts, 02114
United States
Local Institution - 0040
Boston, Massachusetts, 02135-2907
United States
Local Institution - 0472
Ann Arbor, Michigan, 48109-5000
United States
Local Institution - 0096
Chesterfield, Missouri, 63017-3425
United States
Local Institution - 0174
St Louis, Missouri, 63110-1010
United States
Local Institution - 0154
Mount Kisco, New York, 10549-3417
United States
Local Institution - 0433
Durham, North Carolina, 27710
United States
Local Institution - 0366
Wilmington, North Carolina, 28412
United States
Local Institution - 0368
Winston-Salem, North Carolina, 27103
United States
Local Institution - 0201
Cincinnati, Ohio, 45267-0595
United States
Local Institution - 0197
Columbus, Ohio, 43201
United States
Local Institution - 0417
Toledo, Ohio, 43608-2603
United States
Local Institution - 0181
Oklahoma City, Oklahoma, 73104-5417
United States
Local Institution - 0373
Tulsa, Oklahoma, 74133
United States
Local Institution - 0021
Portland, Oregon, 97239-3011
United States
Local Institution - 0067
Hershey, Pennsylvania, 17033-2360
United States
Local Institution - 0406
Philadelphia, Pennsylvania, 19104-5161
United States
Local Institution - 0388
Philadelphia, Pennsylvania, 19107-5109
United States
Local Institution - 0199
Philadelphia, Pennsylvania, 19140-5103
United States
Local Institution - 0202
Pittsburgh, Pennsylvania, 15213
United States
Local Institution - 0346
Wynnewood, Pennsylvania, 19096-3432
United States
Local Institution - 0375
Anderson, South Carolina, 29621
United States
Local Institution - 0188
Charleston, South Carolina, 29425
United States
Local Institution - 0400
Nashville, Tennessee, 37204
United States
Local Institution - 0073
Dallas, Texas, 75235-5351
United States
Local Institution - 0377
Dallas, Texas, 75245-2017
United States
Local Institution - 0039
Houston, Texas, 77030-4202
United States
Local Institution - 0097
Houston, Texas, 77030
United States
Local Institution - 0029
McKinney, Texas, 75069
United States
Local Institution - 0048
San Antonio, Texas, 78229-4404
United States
Local Institution - 0027
Salt Lake City, Utah, 84108
United States
Local Institution - 0184
Richmond, Virginia, 23298
United States
Local Institution - 0191
Everett, Washington, 98208-6526
United States
Local Institution - 0362
Seattle, Washington, 98195
United States

Collaborators and Investigators

Sponsor: Bristol-Myers Squibb

  • Bristol-Myers Squibb, STUDY_DIRECTOR, Bristol-Myers Squibb

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-14
Study Completion Date2026-10-26

Study Record Updates

Study Start Date2023-09-14
Study Completion Date2026-10-26

Terms related to this study

Keywords Provided by Researchers

  • BMS-986278
  • LPA1 antagonist
  • IPF
  • Pulmonary fibrosis

Additional Relevant MeSH Terms

  • Idiopathic Pulmonary Fibrosis